NIR-I Dye-Based Probe: A New Window for Bimodal Tumor Theranostics
Near-infrared (NIR, 650–1700 nm) bioimaging has emerged as a powerful strategy in tumor diagnosis. In particular, NIR-I fluorescence imaging (650–950 nm) has drawn more attention, benefiting from the high quantum yield and good biocompatibility. Since their biomedical applications are slightly limit...
Main Authors: | Fan Zheng, Xueyan Huang, Jipeng Ding, Anyao Bi, Shifen Wang, Fei Chen, Wenbin Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2022.859948/full |
Similar Items
-
Silica micro/nanospheres for theranostics: from bimodal MRI and fluorescent imaging probes to cancer therapy
by: Shanka Walia, et al.
Published: (2015-02-01) -
Functional insights from targeted imaging BACE1: the first near-infrared fluorescent probe for Alzheimer’s disease diagnosis
by: Anyao Bi, et al.
Published: (2022-12-01) -
Recent Advances of NIR-II Emissive Semiconducting Polymer Dots for In Vivo Tumor Fluorescence Imaging and Theranostics
by: Qidong Wei, et al.
Published: (2022-12-01) -
Recent Advances in Rare-Earth-Doped Nanoparticles for NIR-II Imaging and Cancer Theranostics
by: Zhenfeng Yu, et al.
Published: (2020-06-01) -
Temporal-Spatial Features of Intention Understanding Based on EEG-fNIRS Bimodal Measurement
by: Sheng Ge, et al.
Published: (2017-01-01)